Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 8, 2003 - Issue 2
Submit an article Journal homepage
54
Views
4
CrossRef citations to date
0
Altmetric
Review

Emerging therapies for female sexual dysfunction

Robert Taylor Segraves Department of Psychiatry, MetroHealth Medical Center, 2500 Metrohealth Drive, Cleveland, Ohio 44109-1998, USA. [email protected]
Pages 515-522 | Published online: 02 Mar 2005

Bibliography

  • SEGRAVES RT: Historical and international context of nosology of female sexual disorders.' Sex Marital Ther: (2001) 27(2):205–208.
  • TASKFORCE ON DSM-IV: Diagnostic and Statistical Manua] of Mental Disorders American Psychiatric Association, Washington DC (1994).
  • SEGRAVES RT, SEGRAVES KB: Female sexual disorders. In: Psychological Aspects of Women's Health Stotland N, Stewart D (Eds), American Psychiatric Association, Washington DC (2001):379–400.
  • KOEHLER JD: Sexual dysfunction. In: Primary care M Obstetrics and Gynecology Sanfilippo J, Smith R (Eds), Springer, New York (1998):485–524.
  • BASSON R, BERMAN J, BURNETT A et al.: Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications. J. Urol. (2000) 163(3):888–893.
  • •Consensus group recommendations for change in nosology.
  • LAUMANN EO, GAGNON JH, MICHAEL RT, MICHAELS S: The social organization of sexuality: sexual practices M the United States. Laumann EO, Gagnon JH, Michael RT, Michaels S (Eds), University of Chicago Press, Chicago, USA (1994).
  • LAUMANN EO, PAIK A, ROSEN RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA (1999) 281(6):537–544.
  • ••Study of prevalence of sexual dysfunction inthe US.
  • HAWTON K: Sexual function in a community sample of middle-aged women with partners: effects of age, socioeconomic, psychiatric, gynecological and menopausal factors. Arch. Sex. Behav. (1995) 23(4)375–395.
  • DUNN KM: Association of sexual problems with social, psychological and physical problems in men and women: a cross sectional survey. Epidemiol Community Health (1999) 53(3):144–148.
  • DUNN KM: Satisfaction in the sex life of a general population sample. J. Sex Marital Ther. (2000) 26(2):141–151.
  • ••Epidemiology of sexual dysfunctionin the UK.
  • FUGL-MEYER KS: Epidemiology of female sexual dysfunction. Paper presented at Female Sexual Function Forum. Boston, Massachusetts, USA (2001).
  • ••Epidemiology of sexual dysfunctionin Sweden.
  • SEGRAVES KB, SEGRAVES RT: Hypoactive sexual desire disorder: prevalence and comorbidity in 906 patients. Sex Marital Ther. (1991) 17(1):1–9.
  • •Study of comorbidity of sexual dysfunction.
  • KADRI N, MCHICHI A, MCHAKRA T: Sexual dysfunction in women: population based epidemiological study. Arch. Women Men] Health (2003) 5(2):59–63.
  • BILLIPS KL, BERMAN L, BERMAN J, METZ M, GLENNON M, GOLDSTEIN I: A new non-pharmacological vacuum pump therapy for female sexual dysfunction. " Sex Marital Ther: (2001) 27(2):435–442.
  • •Description of FDA approved clitoral vacuum pump.
  • SEGRAVES RT: Female sexual disorders: pychiatric aspects. Can. Psychiatry (2002) 47(5):419–425.
  • •Review of psychiatric aspects female sexual dysfunction.
  • SEGRAVES T, ALTHOF S: Psychotherapy and pharmacotherapy for sexual dysfunctions. In: A guide to treatments that work. 2nd edition. Nathan P, Gorman J (Eds), Oxford University Press, New York (2002):497–524.
  • BASSON R: Women's sexual desire-disordered or misunderstood. J. Sex Marital Ther: (2002) 47\(Suppl. 1):17–28.
  • •Discussion of criteria for diagnosis of female sexual dysfunction.
  • BARTIK B, GOLDBERG J: Female sexual arousal disorder. In: Principles and Practice of Sex Therapy Leiblum S, Rosen R (Eds), Guilford, New York (2000):85–117.
  • ROSEN R, PHILLIPS N, GENDRANO N, FERGUSON D: Oral phentolamine and female sexual arousal disorder: a pilot study. J. Sex Marital The]: (1999) 25(2):137–144.
  • RUBIO-AURILOES E, LOPEZ M, LIPEZKER C et al.: Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study. I Sex Marital The]: (2002) 28(2):205–215.
  • BECHER E, BECHARA A, CASABE A: Clitoral hemodynamic changes after a topical application of alprostadil. J. Sex Marital The]: (2001) 27(5):405–410.
  • ISLAM I, MITCHEL J, ROSEN R et al: Topical alprostadil in the treatment of female sexual arousal disorder: a pilot study. J. Sex Marital The]: (2001) 27(5):531–540.
  • MINARRIZ R, KIM SW, KIM NN, TRAISH A, GOLDSTEIN I: A review of the physiology and pharmacology of peripheral (vaginal and clitoris) female genital arousal in the animal model. Urol. (2003) 170:(2):40–44.
  • •Review of physiology of female sexual response.
  • CLOUGH J: CNS-targeted sexual dysfunction drug for men and women. Drug Discov. Today (2002) 7(9):492–493.
  • ROSEN R, MCKENNA K: PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Annu. Rev. Sex Res. (2003) 13(1):36–88.
  • ROSEN R: Sexual function assessment and the role of vasoactive drugs in female sexual dysfunction. Arch. Sex. Behav. (2002) 31(5)439–444.
  • •Review of use of vasoactive drugs in females.
  • BASSON R: Female sexual response: the role of drugs in the management of female sexual dysfunction. Obstet. Gynecol (2001) 98(2):350–353.
  • ••Review of data concerning use ofvasoactive drugs and hormonal therapy of female sexual dysfunction.
  • LAAN E, VAN LUNSEN R, EVERAERD W, RILEY A, SCOTT E, BOOLELL M: The enhancement of vaginal vasocongestion in healthy premenopausal women. I Womens Health Gend. Based Med. (2002) 11(4):357–365.
  • ••Review of discrepancy between objectiveand subjective measures of sexual arousal.
  • BERMAN J, BERMAN L, TOLER S, GILL J, HAUGHIE S: Efficacy and tolerability of sildenafil citrate in women with sexual arousal disorder: a double-blind, placebo-controlled study. Paper presented at the International Society for the Study of Women's Sexual Health, Vancouver, Canada (2002).
  • BROTTO L, BASSON R: Sildenafil citratein estrogenized women with acquired genital arousal disorder and impaired orgasm: predictive utility of photoplethysmography. Paper presented at the International Society for the Study of Women's Sexual Health, Vancouver, Canada (2002).
  • BACHMANN G, BANCROFT J, BRAUNSTEIN G et al.: Female androgen insufficency: the Princeton consensus statement on definition, classification and assessment. Fertil. Steil]. (2002) 77(4):660–665.
  • •Consensus statement of use of androgens in females.
  • SHERWIN BB: Use of combined estrogen-androgen preparation in the postmenopause: evidence form clinical studies. Int. J. Feral. Womens Med. (1998) 43(2):98–103.
  • SHERWIN B, GELFAND M: The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom. Med. (1987) 49(4):397–409.
  • ••Controlled study demonstrating prosexualeffect of androgen therapy.
  • SARREL PM: Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. Womens Health Gend. Based Med. (2000) 9\(Suppl. 2):S25–S32.
  • GUAY A, MUNARRIZ R, JACOBSON J et al.: Androgen values in pre-menopausal women without sexual dysfunction. Paper presented at the International Socieg, for the Study of Women's Sexual Health, Vancouver, Canada (2002).
  • TUITEN A, VAN HONK J, KOPPESCHAAR H, BERNAARDS C, THIJSSEN J, VERBATEN R: Time course of effects of testosterone administration on sexual arousal in women. Arch. Gen. Psychiatry(2000) 57(2):149–153.
  • ••Controlled study of effect of androgen onsexual arousal.
  • SHIFREN J, BRAUNSTEIN G, SIMON J et al.: Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl. J. Med. (2000) 343(8):1–8.
  • ••Multi-site study of androgen therapy oflow libido.
  • BASSON E: Androgens and women's sexuality: scientific, clinical and regulatory perspectives. Paper presented at the International Society for the Study of Women's Sexual Health, Vancouver, Canada (2002).
  • MODELSKA K, CUMINGS S: Female sexual dysfunction in postmenopausal women. Am. I Obstet. Gynec. (2003) 188(1):286–293.
  • ••Review of controlled studies of treatmentof female sexual dysfunction.
  • BURGER HG: Selective oestrogen receptor modulators. Horm. Res. (2000) 53\(Suppl. 3):25–29.
  • MODELSKA K, CUMMINGS S: Tibilone for postmenopausal women: systematic review of randomized studies. J. Clio. Endocrinol Metab. (2002) 87(1):1–16.
  • CASTELO-BRANCO C, VICENTE JJ, FIGUERAS F et al.: Comparative effects of estrogens plus androgens and tibilone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas (2000) 15(2):161–168.
  • LANN E, VAN LUNSEN R, EVERAERD W: The effect of tibolone on vaginal blood flow, sexual desire and arousabilty in postmenopausal women. Climacteric (2001) 1(1):28–41.
  • LAL S, DELA VEGA C: Apomorphine and psychopathology. I Neuro/. Neurosurg. Psychiatry (1975) 38(7):22–726.
  • ••First report of erectogenic effectof apomorphine.
  • MELIS MR, ARGIOLAS A: Dopamine and sexual behavior. Neurosci. Biobehav. Rev (1995) 19(1):19–38.
  • •Review of role of dopamine in sexual function.
  • SEGRAVES RT, BARI M, SEGRAVES KB, SPIRNAK P: Effect of apomorphine on penile tumescence in men with psychogenic impotence. I Ilia (1991) 145(6):1174–1175.
  • SEGRAVES RT, CALTON A, CROFT H, WOLF A, WARNOCK J: Bupropion for the treatment of female hypoactive sexual desire disorder. World Congress Sexology Havana, Cuba (2003).
  • ••Controlled study of effect of bupropion onorgasmic function.
  • ARGIOLAS A, MELIS M, MURGIA S, SCHTOTH H: ACTH and alpha-MSH induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors. Brain Res. Bull. (2000) 15 (5):425–431.
  • ALLARD J, BERNABLE J, DERDINGS F, ALEXANDRE L, MCKENNA K, GUILIANO F: Selegeline enhances erectile activity induced by dopamine injection in the paraventricular nucleus of the hypothalamus in anesthetized rats. Pelvipharm Lab. Int. Impel-. Res. (2002) 12 (6):518–522.
  • ROSS PK, PIKE MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. (2000) 92(4):328–32.

Websites

  • ••Report of harmful effect of hormonereplacement therapy.
  • http://www.vasomaxnews.com Vasomax news, 2000.
  • http://www.molecualrdesign.com 2002 Molecular Design International.
  • http://www.vivus.com/fr_setasp?Section=investor & sub=press Vivus news release, 2003.
  • http://www.nexmed.con/products/ products.htm NexMed Products under development, 2003.
  • http://ww.members.tripod.com/-APINET/events-fsd98-th.html New Perspective in the Management of female Sexual Dysfunction, 1998.
  • http://www.NitroMed.com/newsindex.html NitroMed nitric oxide-enhanced medicine.
  • http://www.iddb3/iddb3/iddb3_2/ results_dispay.pritn_display?I_template Purinergic receptor agonists, Inspire Pharmaceuticals.
  • http://www.vivus.com/pdfs/11072002.pdf Vivus Announces.
  • http://www.urology.medsch.ucla.edu/fsmc-clinical_trials.htm FSM Center.
  • http://www.nastech.com/nas_pipeline.htm Product Pipeline.
  • http://www.iddb3.com/iddb3/iddb3_2/ results_display?I_template Oral Liposomal apomorphine, Harvard Scientific.
  • http://www.Boehringer-Ingelheim.com/ corporate/news/2–2 drbanner.htm#top. Boehringer Ingelheim press kit.
  • http://www.competitivetech.net/ technologies.htm#sex Competitive technologies.
  • http://www.eurekalert.org/pub_releases/ 192001-10/jka-ptp10241.php Palatin Technologies.
  • http://www.ferring.com/site/ferring-com/ view.asp?ID=249 Ferring Pharmaceuticals, Ferring Pipeline.
  • http://www.cellegy.com/clinical/ female.html Cellegy Pharmaceuticals, Inc.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.